BMX — BioMaxima SA Cashflow Statement
0.000.00%
Last trade - 00:00
- PLN66.67m
- PLN74.32m
- PLN145.51m
- 84
- 34
- 29
- 45
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.482 | -0.014 | 7.36 | 12.8 | 35.9 |
Depreciation | |||||
Non-Cash Items | 0.05 | -0.101 | 0.16 | 0.023 | -0.838 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.15 | 3.36 | -5.44 | -14.6 | 0.014 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2.12 | 4.93 | 3.97 | -0.132 | 37.1 |
Capital Expenditures | -17.4 | -1.64 | -1.88 | -4.48 | -9.88 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.264 | 0.039 | 0.231 | 1.11 | 2.05 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.2 | -1.6 | -1.65 | -3.37 | -7.83 |
Financing Cash Flow Items | 3.99 | 0.09 | 0.16 | -0.169 | -0.467 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.8 | -3.85 | 1.48 | 2.11 | -19.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.286 | -0.518 | 3.8 | -1.39 | 9.91 |